All news

Stock, preferred shares and warrants could fund research at Jaguar Health (JAGX).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Jaguar Health Inc. (JAGX) filed a prospectus to offer up to $75 million in common stock, preferred stock, warrants, subscription rights, or units to fund working capital, research and development, and other corporate purposes. The company recently completed several financial transactions, including acquiring a minority interest in Napo Therapeutics and converting Series R preferred shares into common stock.

Read original source

JAGX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.